PATENT CLAIM ANALYSIS

Application Number: 15932249
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-02
Patent Classification: ["424", "489000"]

Abstract:
Compositions, methods and systems are provided for pulmonary or nasal delivery of active agents via a metered dose inhaler. In one embodiment, the compositions include a suspension medium, active agent particles, and suspending particles, in which the active agent particles and suspending particles form a co-suspension within the suspension medium.

Claim (Index 63):
The pharmaceutical composition of  claim 62 , wherein the pharmaceutical composition comprises sufficient formoterol to provide a delivered dose of between about 2 \u03bcg and about 10 \u03bcg formoterol per actuation of the device.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 88.0
- Lexical Diversity: 1.54054
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12790605', '12790448', '13281726', '13692904', '13109884']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.858072171327397
- 35 USC 102 Novelty (BERT): 0.5950152770161817
- Combined Prediction Score: 0.8317664818962756
- Mean Citation Score: 579.80172
- Max Citation Score: 598.5851
- Similarity Product: 402.7353720457315

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test